» Articles » PMID: 39583325

Bioactive Porous Composite Implant Guides Mesenchymal Stem Cell Differentiation and Migration to Accelerate Bone Reconstruction

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2024 Nov 25
PMID 39583325
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Delayed healing and non-healing of bone defects pose significant challenges in clinical practice, with metal materials increasingly recognized for their significance in addressing these issues. Among these materials, Strontium (Sr) and Zinc (Zn) have emerged as promising agents for promoting bone repair. Building upon this insight, this research evaluates the impact of a porous Sr@Zn@SiO nanocomposite implant on bone regeneration, aiming to advance the field of bone repair.

Methods: The preparation of the Sr@Zn@SiO composite implant involves various techniques such as roasting, centrifugation, and washing. The material's composition is examined, and its microstructure and element distribution are analyzed using TEM and elemental scanning technology. In vitro experiments entail the isolation and characterization of BMSCs followed by safety assessments of the implant material, evaluation of cell migration capabilities, and relevant proliferation markers. Mechanistically, this study delves into key targets associated with significant changes in the osteogenic process. In vivo experiments involve establishing a rat femur bone defect model, followed by assessment of the osteogenic potential of Sr@Zn@SiO using Micro-CT imaging and tissue section staining.

Results: Through in vivo and in vitro investigations, we validate the osteogenic efficacy of the Sr@Zn@SiO composite implant. In vitro analyses demonstrate that porous Sr@Zn@SiO nanocomposite materials upregulate BMP-2 expression, leading to the activation of Smad1/5/9 phosphorylation and subsequent activation of downstream osteogenic genes, culminating in BMSCs osteogenic differentiation and bone proliferation. And the migration of BMSCs is closely related to the high expression of CXCL12/CXCR4, which will also provide the conditions for osteogenesis. In vivo, the osteogenic ability of Sr@Zn@SiO was also confirmed in rats.

Conclusion: In our research, the porous Sr@Zn@SiO composite implant displays prominent osteogenic effect and promotes the migration and differentiation of BMSCs to promote bone defect healing. This bioactive implant has surgical application potential in the future.

References
1.
Agas D, Sabbieti M, Marchetti L, Xiao L, Hurley M . FGF-2 enhances Runx-2/Smads nuclear localization in BMP-2 canonical signaling in osteoblasts. J Cell Physiol. 2013; 228(11):2149-58. DOI: 10.1002/jcp.24382. View

2.
Jeong M, Jung Y, Yoon J, Kang J, Lee S, Back W . Porous Silicon-Based Nanomedicine for Simultaneous Management of Joint Inflammation and Bone Erosion in Rheumatoid Arthritis. ACS Nano. 2022; 16(10):16118-16132. DOI: 10.1021/acsnano.2c04491. View

3.
Li J, Xiong S, Ding L, Zeng J, Qiu P, Zhou J . The mechanism research of non-Smad dependent TAK1 signaling pathway in the treatment of bone defects by recombination BMP-2-loaded hollow hydroxyapatite microspheres/chitosan composite. J Mater Sci Mater Med. 2019; 30(12):130. DOI: 10.1007/s10856-019-6340-9. View

4.
Uzieliene I, Bironaite D, Bagdonas E, Pachaleva J, Sobolev A, Tsai W . The Effects of Mechanical Load on Chondrogenic Responses of Bone Marrow Mesenchymal Stem Cells and Chondrocytes Encapsulated in Chondroitin Sulfate-Based Hydrogel. Int J Mol Sci. 2023; 24(3). PMC: 9918200. DOI: 10.3390/ijms24032915. View

5.
Fielding G, Bose S . SiO2 and ZnO dopants in three-dimensionally printed tricalcium phosphate bone tissue engineering scaffolds enhance osteogenesis and angiogenesis in vivo. Acta Biomater. 2013; 9(11):9137-48. PMC: 3825403. DOI: 10.1016/j.actbio.2013.07.009. View